Clinical Trial

Topical Use of 2% Tofacitinib for Nail Psoriasis: an Exploratory Clinical Study

Name: Topical Use of 2% Tofacitinib for Nail Psoriasis: an Exploratory Clinical Study — clinical trial record (NCT07313072)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

To evaluate the efficacy and safety of topical 2% tofacitinib nail lacquer in nail psoriasis, using the NAPSI and DLQI scales before and after 26 weeks of treatment.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-12-22.

Trial Details

NCT Number	NCT07313072
Lead Sponsor	Hexsel Dermatology Clinic
Conditions	Nail Psoriasis
Enrollment	10 participants
Start Date	2026-03
Primary Completion	2027-01 (estimated)
Study Completion	2027-03 (estimated)
Updated on ClinicalTrials.gov	2026-03-18